These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27993573)
1. Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease. Ladapo JA; Budoff M; Sharp D; Zapien M; Huang L; Maniet B; Herman L; Monane M Am J Med; 2017 Apr; 130(4):482.e11-482.e17. PubMed ID: 27993573 [TBL] [Abstract][Full Text] [Related]
2. The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET Registry. Gul B; Lansky A; Budoff MJ; Sharp D; Maniet B; Herman L; Kuo JZ; Huang L; Monane M; Ladapo JA J Womens Health (Larchmt); 2019 May; 28(5):728-735. PubMed ID: 30653377 [No Abstract] [Full Text] [Related]
3. Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery Disease. Ladapo JA; Budoff MJ; Sharp D; Kuo JZ; Huang L; Maniet B; Herman L; Monane M J Am Geriatr Soc; 2018 Feb; 66(2):309-315. PubMed ID: 29210056 [TBL] [Abstract][Full Text] [Related]
4. Economic Outcomes of a Precision Medicine Blood Test To Assess Obstructive Coronary Artery Disease: Results from the PRESET Registry. Ladapo JA; Budoff MJ; Azarmina P; Sharp D; Baker A; Maniet B; Herman L; Monane M Manag Care; 2018 Jun; 27(6):34-40. PubMed ID: 29989911 [TBL] [Abstract][Full Text] [Related]
5. Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive coronary artery disease: summary results from two ambulatory care studies in primary care. Ladapo JA; Herman L; Weiner BH; Rhees B; Castle L; Monane M; McPherson JA Menopause; 2015 Nov; 22(11):1224-30. PubMed ID: 25828395 [TBL] [Abstract][Full Text] [Related]
6. An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: Insights from the Prospective Multicenter Imaging Study for Evaluation of Chest Pain (PROMISE) trial. Voora D; Coles A; Lee KL; Hoffmann U; Wingrove JA; Rhees B; Huang L; Daniels SE; Monane M; Rosenberg S; Shah SH; Kraus WE; Ginsburg GS; Douglas PS Am Heart J; 2017 Feb; 184():133-140. PubMed ID: 28224927 [TBL] [Abstract][Full Text] [Related]
7. Utility of a genomic-based, personalized medicine test in patients presenting with symptoms suggesting coronary artery disease. Herman L; Froelich J; Kanelos D; St Amant R; Yau M; Rhees B; Monane M; McPherson J J Am Board Fam Med; 2014; 27(2):258-67. PubMed ID: 24610188 [TBL] [Abstract][Full Text] [Related]
8. Enhanced assessment of chest pain and related symptoms in the primary care setting through the use of a novel personalized medicine genomic test: results from a prospective registry study. Ladapo JA; Lyons H; Yau M; Rich P; Newton D; Bruce-Mensah K; Johnson A; Zhou Y; Stemkowski S; Monane M Am J Med Qual; 2015; 30(4):345-52. PubMed ID: 24798176 [TBL] [Abstract][Full Text] [Related]
9. The clinical utility of gene expression testing on the diagnostic evaluation of patients presenting to the cardiologist with symptoms of suspected obstructive coronary artery disease: results from the IMPACT (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trial. McPherson JA; Davis K; Yau M; Beineke P; Rosenberg S; Monane M; Fredi JL Crit Pathw Cardiol; 2013 Jun; 12(2):37-42. PubMed ID: 23680805 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease: data from the International Observational CLARIFY Registry. Steg PG; Greenlaw N; Tendera M; Tardif JC; Ferrari R; Al-Zaibag M; Dorian P; Hu D; Shalnova S; Sokn FJ; Ford I; Fox KM; JAMA Intern Med; 2014 Oct; 174(10):1651-9. PubMed ID: 25110899 [TBL] [Abstract][Full Text] [Related]
12. Sex Differences in Demographics, Risk Factors, Presentation, and Noninvasive Testing in Stable Outpatients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial. Hemal K; Pagidipati NJ; Coles A; Dolor RJ; Mark DB; Pellikka PA; Hoffmann U; Litwin SE; Daubert MA; Shah SH; Ariani K; Bullock-Palmer RP; Martinez B; Lee KL; Douglas PS JACC Cardiovasc Imaging; 2016 Apr; 9(4):337-46. PubMed ID: 27017234 [TBL] [Abstract][Full Text] [Related]
13. Low diagnostic yield of elective coronary angiography. Patel MR; Peterson ED; Dai D; Brennan JM; Redberg RF; Anderson HV; Brindis RG; Douglas PS N Engl J Med; 2010 Mar; 362(10):886-95. PubMed ID: 20220183 [TBL] [Abstract][Full Text] [Related]
14. Management of outpatients in France with stable coronary artery disease. Findings from the prospeCtive observational LongitudinAl RegIstry oF patients with stable coronary arterY disease (CLARIFY) registry. Danchin N; Ferrieres J; Guenoun M; Cattan S; Rushton-Smith SK; Greenlaw N; Ferrari R; Steg PG; Arch Cardiovasc Dis; 2014; 107(8-9):452-61. PubMed ID: 25128934 [TBL] [Abstract][Full Text] [Related]
15. Cardiac computed tomographic angiography in an outpatient setting: an analysis of clinical outcomes over a 40-month period. Gopal A; Nasir K; Ahmadi N; Gul K; Tiano J; Flores M; Young E; Witteman AM; Holland TC; Flores F; Mao SS; Budoff MJ J Cardiovasc Comput Tomogr; 2009; 3(2):90-5. PubMed ID: 19269915 [TBL] [Abstract][Full Text] [Related]
16. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study. Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199 [TBL] [Abstract][Full Text] [Related]
17. A gender-specific blood-based gene expression score for assessing obstructive coronary artery disease in nondiabetic patients: results of the Personalized Risk Evaluation and Diagnosis in the Coronary Tree (PREDICT) trial. Lansky A; Elashoff MR; Ng V; McPherson J; Lazar D; Kraus WE; Voros S; Schwartz RS; Topol EJ Am Heart J; 2012 Sep; 164(3):320-6. PubMed ID: 22980297 [TBL] [Abstract][Full Text] [Related]
18. Abnormal heart-rate response during cardiopulmonary exercise testing identifies cardiac dysfunction in symptomatic patients with non-obstructive coronary artery disease. Chaudhry S; Kumar N; Behbahani H; Bagai A; Singh BK; Menasco N; Lewis GD; Sperling L; Myers J Int J Cardiol; 2017 Feb; 228():114-121. PubMed ID: 27863351 [TBL] [Abstract][Full Text] [Related]
19. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Ferrari R; Abergel H; Ford I; Fox KM; Greenlaw N; Steg PG; Hu D; Tendera M; Tardif JC; Int J Cardiol; 2013 Sep; 167(6):2938-43. PubMed ID: 22985742 [TBL] [Abstract][Full Text] [Related]
20. Comparison of different cardiac risk scores for coronary artery disease in symptomatic women: do female-specific risk factors matter? Rademaker AA; Danad I; Groothuis JG; Heymans MW; Marcu CB; Knaapen P; Appelman YE Eur J Prev Cardiol; 2014 Nov; 21(11):1443-50. PubMed ID: 23804558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]